PTGS2 and endometrial carcinoma: Akt signaling has been reported to upregulate COX-2 expression through the NF-kB/IkB pathway in mutated PTEN endometrial carcinoma cells [54]; α-mangostin may be able to reduce COX-2 expression through Akt dephosphorylation.